SCHEMBL10284259

SCHEMBL10284259

Cc1cc(/N=N\c2c(S(=O)(=O)O)cc3c(S(=O)(=O)O)c(/N=N\c4c(S(=O)(=O)O)cc5c(S(=O)(=O)O)c(N=Nc6cc(S(=O)(=O)O)c7cc(S(=O)(=O)O)c(/N=N\c8ccc([N+](=O)[O-])cc8S(=O)(=O)O)c(O)c7c6N)ccc5c4O)ccc3c2O)c(OCCCS(=O)(=O)O)cc1/N=N\c1cc(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(O)c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 10/20 0.45
▸ PHLPP2 Q6ZVD8 1/20 0.39
▸ PRMT1 Q99873 1/20 0.39
▸ MEN1 O00255 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ APEX1 P27695 1/20 0.36
▸ CYP1A2 P05177 3/20 0.36
▸ ALDH1A1 P00352 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ CYP2C9 P11712 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ DNASE1L3 Q13609 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ ALOX12 P18054 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11930420 1.00 ENPP2 (0.45) ENPP2PHLPP2PRMT1MEN1HTT
SCHEMBL6126122 1.00 ENPP2 (0.45) ENPP2PHLPP2PRMT1MEN1HTT
SCHEMBL6125340 0.98 ENPP2 (0.43) ENPP2PHLPP2PRMT1MEN1HTT
SCHEMBL6126201 0.97 ENPP2 (0.43) ENPP2PHLPP2PRMT1MEN1HTT
SCHEMBL13852030 0.97 ENPP2 (0.46) ENPP2PHLPP2PRMT1MEN1HTT
SCHEMBL6125343 0.96 ENPP2 (0.43) ENPP2PHLPP2PRMT1MEN1HTT
SCHEMBL13852303 0.96 ENPP2 (0.40) ENPP2PHLPP2PRMT1MEN1HTT
SCHEMBL6125335 0.96 ENPP2 (0.40) ENPP2PHLPP2PRMT1MEN1HTT
SCHEMBL10284613 0.94 ENPP2 (0.45) ENPP2PHLPP2PRMT1MEN1HTT
SCHEMBL13852307 0.94 ENPP2 (0.38) ENPP2PHLPP2PRMT1MEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8167991-B2 Trisazo compound, ink composition, recording method, and colored article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2012-05-01 — — US disclosed
US-20090118479-A1 Azo compound, ink composition, recording method and colored article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-05-07 — — US disclosed
US-20090062545-A1 Trisazo Compound, Ink Composition, Recording Method, and Colored Article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-03-05 — — US disclosed
EP-1889882-A1 AZO COMPOUND, INK COMPOSITION, RECORDING METHOD AND COLORED MATTER Nippon Kayaku Kabushiki Kaisha (JP) 2008-02-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062545-A1 Trisazo Compound, Ink Composition, Recording Method, and Colored Article JAK1, TMT1A, CDK1 ENPP2 4384/4885PHLPP2 2764/4885PRMT1 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback